Techno Medica Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Techno Medica Co., Ltd. carries a market capitalization of 13.33B, placing it among publicly traded companies globally. Its enterprise value stands at 6.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.33B |
| Enterprise Value | 6.01B |
Share Statistics
Techno Medica Co., Ltd. currently has 6.91M shares outstanding.
| Shares Outstanding | 6.91M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Techno Medica Co., Ltd. trades at a trailing price-to-earnings ratio of 10.83. The price-to-sales ratio is 1.42, and the price-to-book ratio stands at 1.82.
| PE Ratio | 10.83 |
| PS Ratio | 1.42 |
| PB Ratio | 1.82 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 0.58 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.27 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.58 |
| EV / EBITDA | 3.27 |
| EV / EBIT | 3.27 |
| EV / FCF | N/A |
Financial Position
Techno Medica Co., Ltd. maintains a current ratio of 4.49, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.49 |
| Quick Ratio | 2.56 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Techno Medica Co., Ltd. posts a return on equity of 17.78 and a return on invested capital of 8.63.
| Return on Equity (ROE) | 17.78 |
| Return on Assets (ROA) | 7.31 |
| Return on Invested Capital (ROIC) | 8.63 |
| Return on Capital Employed (ROCE) | 17.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.55 |
Taxes
Over the trailing twelve months, Techno Medica Co., Ltd. has paid 512.49M in income taxes, reflecting an effective tax rate of 27.54.
| Income Tax | 512.49M |
| Effective Tax Rate | 27.54 |
Stock Price Statistics
Techno Medica Co., Ltd.'s stock has gained approximately 6.83761% over the past 52 weeks. The 50-day moving average sits at 2,062.36, while the 200-day moving average is 2,164.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6.83761% |
| 50-Day Moving Average | 2,062.36 |
| 200-Day Moving Average | 2,164.45 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Techno Medica Co., Ltd. generated 10.28B in revenue and converted that into 1.35B in net income, yielding earnings per share of 163.44. EBITDA reached 1.84B, while operating income came in at 1.84B.
| Revenue | 10.28B |
| Gross Profit | 5.15B |
| Operating Income | 1.84B |
| Pretax Income | 1.86B |
| Net Income | 1.35B |
| EBITDA | 1.84B |
| EBIT | 1.84B |
| Earnings Per Share (EPS) | 163.44 |
Balance Sheet
Total book value stands at 8.00B, with working capital of 11.72B providing operational flexibility.
| Cash & Cash Equivalents | 8.59B |
| Total Debt | N/A |
| Net Debt | -8.59B |
| Equity (Book Value) | 8.00B |
| Book Value Per Share | 969.93 |
| Working Capital | 11.72B |
Margins
Techno Medica Co., Ltd. operates with a gross margin of 50.10, reflecting its pricing power and cost economics. The operating margin of 17.89 and net profit margin of 13.11 provide insight into operational efficiency.
| Gross Margin | 50.10 |
| Operating Margin | 17.89 |
| Pretax Margin | 18.09 |
| Profit Margin | 13.11 |
| EBITDA Margin | 17.89 |
Stock Splits
Techno Medica Co., Ltd.'s most recent stock split took place on September 26, 2013 with a 1:300 split ratio.
| Last Split Date | 9/26/2013 |
| Split Ratio | 1:300 |
Scores
Techno Medica Co., Ltd. posts an Altman Z-Score of 4.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.73 |